Huayu Pill Promotes Fluorescent Doxorubicin Delivery to Tumors in Mouse Model of Lung Cancer
- 1 July 2021
- journal article
- research article
- Published by Springer Nature in Chinese Journal of Integrated Medicine
- Vol. 27 (7), 514-519
- https://doi.org/10.1007/s11655-020-3191-7
Abstract
Objective:To study the effect and mechanism of Huayu Wan in combination of chemotherapy of tumor treatment.Methods:HYW serum was added in Lewis cells to assess its impact on fluorescent doxorubicin delivery in vitro. Then, Lewis tumor cells was implanted in C57BL/6 mice via xenograft transplantation. Tumor growth was measured and signal intensity corresponding to blood flow was assessed by laser doppler perfusion imaging (LDPI). Finally, the effect of HYW on the effificacy of doxorubicin was studied.Results:HYW can improve the transfer of fluorescent doxorubicin into cells. The blood flow signal in the tumor tissues of the HYW group was higher than that of the control group (P<0.01). Furthermore, HYW improved drug delivery of doxorubicin to tumor tissues, and this activity was associated with HYW-induced microvascular proliferation (P<0.01).Conclusions:HYW can promote microangiogenesis and increase blood supply in tumor tissues, which in turn may increase the risk of metastasis. At the same time, HYW increases drug delivery and improves the effificacy of chemotherapy drugs through vascular proliferation. Therefore, rational judgment must be exercised when considering applying HYW to an antitumor regimen.Keywords
This publication has 24 references indexed in Scilit:
- Codelivery of doxorubicin and triptolide with reduction-sensitive lipid–polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatmentInternational Journal of Nanomedicine, 2017
- Complementary Chinese herbal medicine therapy improves survival of patients with gastric cancer in Taiwan: A nationwide retrospective matched-cohort studyJournal of Ethnopharmacology, 2017
- Prescription frequency and patterns of Chinese herbal medicine for liver cancer patients in Taiwan: a cross-sectional analysis of the National Health Insurance Research DatabaseBMC Complementary and Alternative Medicine, 2017
- Comprehensive treatment with Chinese medicine in patients with advanced non-small cell lung cancer: A multicenter, prospective, cohort studyChinese Journal of Integrated Medicine, 2016
- Characteristics of Traditional Chinese Medicine Use in Pediatric Cancer Patients: A Nationwide, Retrospective, Taiwanese-Registry, Population-Based StudyIntegrative Cancer Therapies, 2016
- Chinese herbal medicine as maintenance therapy for improving the quality of life for advanced non-small cell lung cancer patientsComplementary Therapies in Medicine, 2016
- Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancerCancer Treatment Reviews, 2016
- Cancer statistics in China, 2015CA: A Cancer Journal for Clinicians, 2016
- Chinese herbal medicine for oesophageal cancerCochrane Database of Systematic Reviews, 2016
- Clinical study on severe acute pancreatitis complicated by hepatic insufficiencyJournal of Chinese Integrative Medicine, 2006